Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Vaginal Suppositories Containing Combination of Natamycin and Lactulose in Treatment of Vulvovaginal Candidiasis: International, Randomized, Controlled, Superiority Clinical Trial

NCT06411314 is registered in ClinicalTrials.gov with Avva Rus, JSC as lead sponsor.

NCT NCT06411314
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06411314 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Vaginal Suppositories Containing Combination of Natamycin and Lactulose in Treatment of Vulvovaginal Candidiasis: International, Randomized, Controlled, Superiority Clinical Trial
Lead sponsor
Avva Rus, JSC
Phase
Phase 3
Overall status
Completed
Start date
December 29, 2022
Completion date
September 22, 2023
Enrollment
218 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

vulvovaginal candidiasis, genital